Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein post-translational modifications, going beyond degradation to restore protein function, repair signaling, and amplify endogenous disease-fighting mechanisms. Photys was co-founded by the Broad Institute’s leading bifunctional chemist, Amit Choudhary, and the Longwood Fund, alongside a scientific advisory board comprised of distinguished scientists and drug developers – MIT’s Angela Koehler, Salk’s Tony Hunter, Berkeley’s Dan Nomura, MPM’s Wendy Young, and Dana Farber’s Eric Fischer.

Photys

(To Be Hired)

Bryan Song

Ed Holson

Emma Seabrook

The executive team at Photys has a history of experience in the venture capital, medical research, and recruiting industries. They have a combined education in biochemistry and organic chemistry from The University of Texas at Austin and the University of Michigan respectively.

CEO and Executive Team

About

Team members

Other teams at Photys

Leadership Team